首页|精神分裂症患者认知功能障碍与其血清Hcy、EGF水平的关系

精神分裂症患者认知功能障碍与其血清Hcy、EGF水平的关系

扫码查看
目的 探讨精神分裂症患者认知功能障碍与血清同型半胱氨酸(homocysteine,Hcy)、表皮生长因子(epidermal growth factor,EGF)水平的关系。方法 回顾性分析2020年1月~2023年1月本院收治的110例精神分裂症患者的临床资料,入院后均使用蒙特利尔认知评估表(Montreal Cognitive Assessment Form,MoCA)评估其认知功能,根据评分结果设为无认知功能障碍组与认知功能障碍组。比较两组一般资料[性别、年龄、身体质量指数(body mass index,BMI)、婚姻状况、吸烟史、饮酒史、使用高含量抗胆碱能药物以及血清Hcy、EGF水平间差异,通过ROC明确血清Hcy、EGF预测精神分裂症患者发生认知功能障碍的价值,通过多因素Logistic回归分析明确精神分裂症患者发生认知功能障碍的危险因素。结果 患者入院后采用MoCA评分评估其认知功能,根据评分结果分组,110例患者中无认知功能障碍发生率63。64%(70/110),认知功能障碍发生率36。36%(40/110),分别设为无认知功能障碍组与认知功能障碍组。两组性别、年龄、BMI、婚姻状况、吸烟史、饮酒史比较差异无统计学意义(P>0。05),无认知功能障碍组使用高含量抗胆碱能药物占比以及血清Hcy、EGF水平显著低于认知功能障碍组,差异有统计学意义(P<0。05)。经ROC分析证实血清Hcy、EGF均可用于首发精神分裂症患者发生认知功能损害的预测,曲线下面积分别为0。974、0。788,均P<0。05。经多因素Logistic回归分析证实,使用高含量抗胆碱能药物、Hcy≥14。575 μmol/L、EGF≥1698。275pg/mL是精神分裂症患者发生认知功能障碍的危险因素,均P<0。05。结论 精神分裂症患者认知功能受诸多因素影响,当Hcy≥14。575 μmol/L、EGF ≥ 1698。275pg/mL时,可用于预测其认知功能障碍。
The influence of serum Hcy and EGF levels on cognitive dysfunction in patients with schizophrenia
Objective To explore the relationship between cognitive dysfunction and serum levels of homocyste-ine(Hcy)and epidermal growth factor(EGF)in patients with schizophrenia.Methods A retrospective analysis was conducted on the clinical data of 110 patients with schizophrenia admitted to our hospital from January 2020 to January 2023.After admission,their cognitive function was evaluated using the Montreal Cognitive Assessment Form(MoCA).According to the scoring results,they were divided into a group without cognitive impairment and a group with cogni-tive impairment.Compare two sets of general data[gender,age,body mass index(BMI),marital status,smoking history,alcohol consumption history,use of high levels of anticholinergic drugs,and differences in serum Hcy and EGF levels].Use ROC to determine the value of serum Hcy and EGF in predicting cognitive dysfunction in patients with schizophrenia.Use multivariate logistic regression analysis to identify risk factors for cognitive dysfunction in patients with schizophrenia.Results After admission,the patients were evaluated for their cognitive function using the MoCA score.According to the score results,the incidence of no cognitive impairment was 63.64%(70/110)in 110 patients,and the incidence of cognitive impairment was 36.36%(40/110).They were divided into the no cognitive impairment group and the cognitive impairment group,respectively.There was no statistically significant difference in gender,age,BMI,marital status,smoking history,and drinking history between the two groups(P>0.05).The proportion of high content anticholinergic drugs used,as well as serum Hcy and EGF,were significantly lower in the non cogni-tive impairment group than in the cognitive impairment group,with a statistically significant difference(P<0.05).After ROC analysis,it was confirmed that serum Hcy and EGF can both be used for predicting cognitive impairment in first-episode schizophrenia patients,with areas under the curve of 0.974 and 0.788,respectively,with P<0.05.Multivariate logistic regression analysis confirmed that the use of high levels of anticholinergic drugs,Hcy ≥ 14.575 μmol/L,and EGF≥1698.275pg/mL were risk factors for cognitive impairment in patients with schizophrenia,all with P<0.05.Conclusion Cognitive function in patients with schizophrenia is influenced by many factors.When Hcy ≥14.575 μmol/L and EGF≥1698.275pg/mL,it can be used to predict cognitive dysfunction.

SchizophreniaHomocysteineEpidermal growth factorCognitive function

帅久红、王学国、龚蔓蕾

展开 >

成都市温江区第三人民医院急性精神科(成都,611130)

精神分裂症 同型半胱氨酸 表皮生长因子 认知功能

四川省医学青年科技项目

21

2024

国际精神病学杂志
中南大学

国际精神病学杂志

CSTPCD
影响因子:1.426
ISSN:1673-2952
年,卷(期):2024.51(1)
  • 15